4523 On Other Exchanges
Symbol
Exchange
4523 is not on other exchanges.

Executive Profile*

Hideki Hayashi

Chief Information Officer and Representative Corporate Officer of Japan Business,Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

59--

Background*

Mr. Hideki Hayashi serves as Chief Information Officer and Representative Corporate Officer of Japan Business at Eisai Co., Ltd., and served as its Representative Corporate Officer of Corporate Planning & Strategy, Chief Product Creation Officer of Eisai Product Creation Systems and Representative Corporate Officer. Mr. Hayashi served as a Deputy President and Chief Product Creation Officer of Eisai Product Creation Systems for Global BD - Chief Executive Officer's special ...

Read Full Background

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088

Japan

Phone: 81 3 3817 3016
Fax: 81 3 3811 6032

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President, Director and Member of Stock Option Committee
Innoviva, Inc.
$721.4K
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$892.6K
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chairman and Chief Executive Officer
Sucampo Pharmaceuticals, Inc.
$565.3K
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Executive Director and Member of Compliance Committee
Almirall, S.A.
€1.1M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EISAI CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.